Vasoplegia clinical trials at UCSF
1 in progress, 0 open to eligible people
Sorry, not yet accepting patients
The purpose of this study is to determine the efficacy and safety of Angiotensin II as a second-line vasopressor (drug that raises the blood pressure) during liver transplantation.
San Francisco, California